Pasithea Therapeutics KTTA Ratios (2020-2026)

NASDAQ KTTA
$0.47 -0.02 (-4.08%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Ratios Dec2020 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 5.28%-11.19%60.45%100.54%
EBT Margin (Quarter) -11,526.14%-19,574.36%-2,097.88%-2,126.06%
EBIT Margin (Quarter) -17,605.34%-25,866.48%-1,944.49%-2,110.77%
EBITDA Margin (Quarter) -17,605.34%-25,866.48%-1,944.49%-2,110.77%
Operating Margin (Quarter) -17,605.34%-25,866.48%-1,944.49%-2,110.77%
Net Margin (Quarter) -2,384.38%-3,449.93%180.73%-1,419.54%
FCF Margin (Quarter) -15,771.77%-14,302.08%-2,116.61%-1,361.84%
Efficiency
Assets Average (Quarter) 37.18M52.20M52.05M51.32M47.39M43.61M40.10M34.40M28.39M24.26M20.04M18.15M17.35M15.36M15.83M15.32M36.94M58.30M
Asset Utilization Ratio (Quarter) 0.01
Leverage & Solvency
Interest Coverage Ratio (Quarter) -2.10-323.62-5.10-6.08-6.01-6.41-6.26-1.59-2.92-6.05-4.94-131.85-7.74
Times Interest Earned (Quarter) -2.10-323.62-5.10-6.08-6.01-6.41-6.26-1.59-2.92-6.05-4.94-131.85-7.74
Valuation
Enterprise Value (Quarter) -0.24M-20.57M-52.97M-50.32M-47.94M-42.40M-33.09M-29.91M-26.77M-19.68M-16.33M-12.01M-7.10M-9.36M-6.92M-5.34M-6.20M-4.22M-55.30M-50.50M
Return Ratios
Return on Sales (Quarter) -0.24%-0.34%0.02%-0.14%
Return on Capital Employed (Quarter) -12.27%-12.29%-17.90%-24.34%-33.50%-38.70%-43.24%-49.17%-62.05%-77.11%-90.79%-92.28%-87.79%-100.89%-97.57%-99.41%-65.26%-38.82%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%